Ofer Zimmerman

893 total citations
18 papers, 563 citations indexed

About

Ofer Zimmerman is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Ofer Zimmerman has authored 18 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Ofer Zimmerman's work include Immunodeficiency and Autoimmune Disorders (7 papers), Blood disorders and treatments (4 papers) and Mosquito-borne diseases and control (3 papers). Ofer Zimmerman is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (7 papers), Blood disorders and treatments (4 papers) and Mosquito-borne diseases and control (3 papers). Ofer Zimmerman collaborates with scholars based in United States, Israel and Netherlands. Ofer Zimmerman's co-authors include Arie Steinvil, Talya Finn, Galit Aviram, Ori Rogowski, Steven M. Holland, Dan Justo, David Zeltser, Christa S. Zerbe, Amir Bar‐Shai and Alexandra F. Freeman and has published in prestigious journals such as Journal of Clinical Investigation, Radiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ofer Zimmerman

17 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Zimmerman United States 12 258 217 193 92 56 18 563
Christel Zufferey Australia 13 221 0.9× 264 1.2× 300 1.6× 63 0.7× 28 0.5× 22 585
R. J. A. Diepersloot Netherlands 13 296 1.1× 136 0.6× 138 0.7× 85 0.9× 32 0.6× 16 591
Gregor Bond Austria 21 255 1.0× 255 1.2× 214 1.1× 211 2.3× 68 1.2× 61 1.3k
Esther Benamu United States 9 230 0.9× 133 0.6× 141 0.7× 19 0.2× 32 0.6× 21 496
Güher Göral Türkiye 14 226 0.9× 187 0.9× 127 0.7× 43 0.5× 39 0.7× 26 560
Barbara Iwańczak Poland 18 187 0.7× 156 0.7× 68 0.4× 258 2.8× 31 0.6× 116 895
Sasijit Vejbaesya Thailand 13 158 0.6× 179 0.8× 186 1.0× 18 0.2× 76 1.4× 27 457
João Santos‐Antunes Portugal 13 271 1.1× 77 0.4× 125 0.6× 222 2.4× 27 0.5× 73 640
Margaret Duffy Ireland 9 197 0.8× 185 0.9× 87 0.5× 32 0.3× 30 0.5× 16 515
Shobha Sehgal India 13 150 0.6× 111 0.5× 92 0.5× 34 0.4× 90 1.6× 59 574

Countries citing papers authored by Ofer Zimmerman

Since Specialization
Citations

This map shows the geographic impact of Ofer Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Zimmerman more than expected).

Fields of papers citing papers by Ofer Zimmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Zimmerman. The network helps show where Ofer Zimmerman may publish in the future.

Co-authorship network of co-authors of Ofer Zimmerman

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Zimmerman. A scholar is included among the top collaborators of Ofer Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Zimmerman. Ofer Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Raju, Saravanan, Alan Sariol, Zhenlu Chong, et al.. (2024). The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses. Cell Reports. 43(10). 114809–114809. 7 indexed citations
2.
Zimmerman, Ofer, et al.. (2024). SEVERE NEUTROPENIA AND SINOPULMONARY INFECTIONS IN A 56-YEAR-OLD WITH ADA2 DEFICIENCY AND TACI HETEROZYGOUS VARIANT. Annals of Allergy Asthma & Immunology. 133(6). S171–S171.
3.
Zimmerman, Ofer, et al.. (2023). Entry receptors — the gateway to alphavirus infection. Journal of Clinical Investigation. 133(2). 27 indexed citations
4.
Blanco-Lobo, Pilar, Beatriz de Felipe, Hector Rodriguez‐Villalobos, et al.. (2022). Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations. Journal of Clinical Immunology. 42(6). 1193–1204. 11 indexed citations
5.
Cooper, Megan A., et al.. (2021). Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity. The Journal of Allergy and Clinical Immunology In Practice. 9(2). 628–639. 9 indexed citations
6.
Kim, Arthur S., Ofer Zimmerman, Julie M. Fox, et al.. (2020). An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis. Cell Host & Microbe. 27(3). 428–440.e9. 31 indexed citations
7.
Zimmerman, Ofer, Peter Olbrich, Alexandra F. Freeman, et al.. (2019). STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation. Frontiers in Immunology. 10. 1433–1433. 46 indexed citations
8.
Paran, Yael, Ronen Ben‐Ami, Ora Halutz, et al.. (2019). Chronic schistosomiasis in African immigrants in Israel. Medicine. 98(52). e18481–e18481. 5 indexed citations
9.
Zimmerman, Ofer, Lindsey B. Rosen, Muthulekha Swamydas, et al.. (2017). Autoimmune Regulator Deficiency Results in a Decrease in STAT1 Levels in Human Monocytes. Frontiers in Immunology. 8. 820–820. 10 indexed citations
10.
Vargas‐Hernández, Alexander, Emily M. Mace, Ofer Zimmerman, et al.. (2017). Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. Journal of Allergy and Clinical Immunology. 141(6). 2142–2155.e5. 72 indexed citations
11.
Zimmerman, Ofer, Berenice Rösler, Christa S. Zerbe, et al.. (2017). Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. Open Forum Infectious Diseases. 4(4). ofx202–ofx202. 44 indexed citations
12.
13.
Paran, Yael, Varda Shalev, Arie Steinvil, et al.. (2013). Thrombosis following acute cytomegalovirus infection: a community prospective study. Annals of Hematology. 92(7). 969–974. 24 indexed citations
14.
Aviram, Galit, Amir Bar‐Shai, Jacob Sosna, et al.. (2010). H1N1 Influenza: Initial Chest Radiographic Findings in Helping Predict Patient Outcome. Radiology. 255(1). 252–259. 76 indexed citations
15.
Atzmony, Lihi, Ora Halutz, Boaz Avidor, et al.. (2010). Incidence of Cytomegalovirus-associated thrombosis and its risk factors: A case-control study. Thrombosis Research. 126(6). e439–e443. 53 indexed citations
16.
Zimmerman, Ofer, Ori Rogowski, Galit Aviram, et al.. (2010). C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infectious Diseases. 10(1). 288–288. 43 indexed citations
17.
Zimmerman, Ofer & Pinchas Halpern. (2004). Opinion survey of analgesia for abdominal pain in Israeli emergency departments.. PubMed. 6(11). 681–5. 14 indexed citations
18.
Zimmerman, Ofer, et al.. (1973). Massive hemoperitoneum from rupture of benign hepatocellular adenoma.. PubMed. 73(2). 181–4. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026